ReignCorp
Official government records, as published. No commentary. Every entry links to its source.
Agencies › Federal Register document
2026-11-09 · Rule · Federal Register document 2026-22792

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

Health and Human Services Department, Centers for Medicare & Medicaid Services

Official abstract: This rule finalizes and codifies the Medicare Drug Price Negotiation Program ("Negotiation Program") and establishes certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program ("Part D Program") as required by the Inflation Reduction Act of 2022. This final rule also finalizes a proposed policy for specific fixed combination drugs that are new formulations.

Read the full document on FederalRegister.gov →Official PDF →
More from Health and Human Services Department →More from Centers for Medicare & Medicaid Services →All federal records →